Suppr超能文献

前列腺导管内癌:39名泌尿外科病理学家的观察者间再现性调查

Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.

作者信息

Iczkowski Kenneth A, Egevad Lars, Ma Jun, Harding-Jackson Nicholas, Algaba Ferran, Billis Athanase, Camparo Philippe, Cheng Liang, Clouston David, Comperat Eva M, Datta Milton W, Evans Andrew G, Griffiths David F, Guo Charles C, Hailemariam Seife, Huang Wei, Humphrey Peter A, Jiang Zhong, Kahane Hillel, Kristiansen Glen, La Rosa Francisco G, Lopez-Beltran Antonio, MacLennan Gregory T, Magi-Galluzzi Cristina, Merrimen Jennifer, Montironi Rodolfo, Osunkoya Adeboye O, Picken Maria M, Rao Nagarjun, Shah Rajal B, Shanks Jonathan H, Shen Steven S, Tawfik Ossama W, True Lawrence D, Van der Kwast Theodorus, Varma Murali, Wheeler Thomas M, Zynger Debra L, Sahr Natasha, Bostwick David G

机构信息

Medical College of Wisconsin, Milwaukee, WI.

Karolinska Institutet, Stockholm, Sweden.

出版信息

Ann Diagn Pathol. 2014 Dec;18(6):333-42. doi: 10.1016/j.anndiagpath.2014.08.010. Epub 2014 Sep 3.

Abstract

The diagnosis of intraductal carcinoma (IDC) of the prostate remains subjective because 3 sets of diagnostic criteria are in use. An internet survey was compiled from 38 photomicrographs showing duct proliferations: 14 signed out as high-grade prostatic intraepithelial neoplasia (HGPIN), 17 IDC, and 7 invasive cribriform/ductal carcinoma. Each image was assessed for the presence of 9 histologic criteria ascribed to IDC. Thirty-nine respondents were asked to rate images as (1) benign/reactive, (2) HGPIN, (3) borderline between HGPIN and IDC, (4) IDC, or (5) invasive cribriform/ductal carcinoma. Intraclass correlation coefficient was 0.68. There was 70% overall agreement with HGPIN, 43% with IDC, and 73% with invasive carcinoma (P < .001, χ(2)). Respondents considered 19 (50%) of 38 cases as IDC candidates, of which 5 (26%) had a two-thirds consensus for IDC; two-thirds consensus for either borderline or IDC was reached in 9 (47%). Two-thirds consensus other than IDC was reached in the remaining 19 of 38 cases, with 15 supporting HGPIN and 4 supporting invasive carcinoma. Findings that differed across diagnostic categories were lumen-spanning neoplastic cells (P < .001), 2× benign duct diameters (P < .001), duct space contours (round, irregular, and branched) (P < .001), papillary growth (P = .048), dense cribriform or solid growth (both P = .023), and comedonecrosis (P = .015). When the 19 of 38 images that attained consensus for HGPIN or invasive carcinoma were removed from consideration, lack of IDC consensus was most often attributable to only loose cribriform growth (5/19), central nuclear maturation (5/19), or comedonecrosis (3/19). Of the 9 histologic criteria, only 1 retained significant correlation with a consensus diagnosis of IDC: the presence of solid areas (P = .038). One case that attained IDC consensus had less than 2× duct enlargement yet still had severe nuclear atypia and nucleomegaly. Six fold nuclear enlargement was not significant (P = .083), although no image had both 6× nuclei and papillary or loose cribriform growth: a combination postulated as sufficient criteria for IDC. Finally, 20.5% of respondents agreed that an isolated diagnosis of IDC on needle biopsy warrants definitive therapy, 20.5% disagreed, and 59.0% considered the decision to depend upon clinicopathologic variables. Although IDC diagnosis remains challenging, we propose these criteria: a lumen-spanning proliferation of neoplastic cells in preexisting ducts with a dense cribriform or partial solid growth pattern. Solid growth, in any part of the duct space, emerges as the most reproducible finding to rule in a diagnosis of IDC. Comedonecrosis is a rarer finding, but in most cases, it should rule in IDC. Duct space enlargement to greater than 2× the diameter of the largest, adjacent benign spaces is usually present in IDC, although there may be rare exceptions.

摘要

前列腺导管内癌(IDC)的诊断仍然具有主观性,因为目前使用着3套诊断标准。我们从38张显示导管增生的显微照片编制了一项网络调查:14张诊断为高级别前列腺上皮内瘤变(HGPIN),17张为IDC,7张为浸润性筛状/导管癌。每张图像都根据9项归因于IDC的组织学标准进行评估。39名受访者被要求将图像评为(1)良性/反应性,(2)HGPIN,(3)HGPIN与IDC之间的临界状态,(4)IDC,或(5)浸润性筛状/导管癌。组内相关系数为0.68。对HGPIN的总体一致性为70%,对IDC的为43%,对浸润性癌的为73%(P <.001,χ(2))。受访者将38例中的19例(50%)视为IDC候选病例,其中5例(26%)对IDC有三分之二的共识;9例(47%)对临界状态或IDC达成了三分之二的共识。在38例中的其余19例中,除IDC外达成了三分之二的共识,15例支持HGPIN,4例支持浸润性癌。不同诊断类别之间存在差异的发现包括跨腔隙的肿瘤细胞(P <.001)、良性导管直径的2倍(P <.001)、导管腔轮廓(圆形、不规则形和分支形)(P <.001)、乳头状生长(P =.048)、致密筛状或实性生长(两者P =.023)以及粉刺样坏死(P =.015)。当从考虑中剔除38张图像中对HGPIN或浸润性癌达成共识的19张后,缺乏IDC共识最常归因于仅疏松筛状生长(5/19)、中央核成熟(5/19)或粉刺样坏死(3/19)。在9项组织学标准中,只有1项与IDC的共识诊断保持显著相关性:实性区域的存在(P =.038)。1例达成IDC共识的病例导管扩张小于2倍,但仍有严重的核异型性和核肿大。核增大6倍并不显著(P =.083),尽管没有图像同时具有6倍核以及乳头状或疏松筛状生长:这种组合被假定为IDC的充分标准。最后,20.5%的受访者同意针吸活检孤立诊断为IDC需要确定性治疗,20.5%不同意该观点,59.0%认为该决定取决于临床病理变量。尽管IDC诊断仍然具有挑战性,但我们提出以下标准:在先前存在的导管内肿瘤细胞的跨腔隙增生,具有致密筛状或部分实性生长模式。导管腔内任何部位的实性生长是诊断IDC最具可重复性的发现。粉刺样坏死是较罕见的发现,但在大多数情况下,它应支持IDC诊断。IDC通常存在导管腔扩张至大于最大相邻良性腔隙直径的2倍,尽管可能有罕见例外。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验